Introduction
Although red cell transfusions have been a mainstay in the treatment of critically ill patients, recent studies have shown an association between packed red blood cell (RBC) transfusion and increased morbidity and mortality in this cohort. [1] [2] [3] [4] Supported by the initial observations of Fowler et al., recent epidemiological data collectively suggest that red cell transfusion is a predisposing condition for the development of lung injury in the critically ill population at risk for ARDS. 5 Indeed, in a cohort of critically ill patients with Acute Lung Injury (ALI), the risk of mortality increased with the number of RBC units transfused, suggesting that each transfusion serves as another "hit" or insult perpetuating lung inflammation and injury. 6 Furthermore, RBC transfusion was found to be an independent predictor for the development of and mortality from ARDS in a prospective study of patients at risk for ARDS, 6 and a predictor of multiple organ failure (MOF) in a cohort of trauma patients. 7 Although the present epidemiological and observational studies highlight an important clinical association between red cell transfusion and ALI, the mechanisms underlying this association have yet to be fully elucidated.
Multiple factors may contribute to the development of lung injury after transfusion in at risk patients. Allogenic leukocytes of red cell transfusates have long been implicated as a source of immunomodulatory effects. 8, 9 However clinical trials of leukoreduction have
shown conflicting results. [8] [9] [10] Recent data from patients given packed red cells (RBC) during cardiac surgery shows that the risk of mortality rises with increasing age of red cells being transfused. 11 This lends credence to the concept that biochemical and
For personal use only. on November 12, 2017 . by guest www.bloodjournal.org From morphological alterations the red cell undergoes with storage, i.e. the "storage lesion", contributes to morbidity associated with RBC transfusion. Independent of storage, prior studies illustrate that erythrocytes have the potential to induce biological activity through various mechanisms. For example, erythrocytes form advanced glycation end products over time, convert eicosinoid mediators, generate reactive oxygen species, and possess chemokine binding activity that can modulate an existing inflammatory state. [12] [13] [14] [15] [16] [17] However, the role of red cell transfusates in the perpetuation or amplification of existing inflammatory responses during critical illness remains unknown.
We have previously shown that erythrocyte Duffy antigen can scavenge chemokines in whole blood stimulated with endotoxin. 18 First recognized as the receptor for the parasite Plasmodium vivax, the Duffy antigen is a minor blood group antigen that binds multiple inflammatory CXC and CC chemokines with high affinity. 12, 14, 19, 20 Intracellular calcium flux does not occur upon chemokine binding to erythrocyte Duffy antigen and chemokines bound to erythrocytes are not accessible to circulating neutrophils. 12 During inflammatory states, we have also shown that erythrocyte Duffy antigen has a more prominent role than endothelial Duffy antigen in chemokine clearance from the lung microvasculature to the systemic circulation. 18 Prior observations of others suggest that red cell Duffy antigen expression may be reduced under standard blood bank conditions. 21 We hypothesized that storage related alterations in Duffy antigen is one 
Materials and Methods

Human study subjects
Healthy volunteers between the ages of 18 and 65 years gave written informed consent for the studies in accordance with the Declaration of Helsinki. All experimental procedures involving human subjects or use of human packed red blood cells (PRBCs) have been approved by the University of Pittsburgh Institutional Review Board.
Isolation of human erythrocytes
Whole blood was obtained via venipuncture and Citrate-Phosphate-Dextrose-Adenine (CPDA, Sigma-Aldrich, St. Louis, MO, USA) solution was added to the whole blood (1 ml CPDA: 9 mls whole blood). Erythrocytes were purified using modifications of a technique described by Beutler et al. 22 The whole blood was passed over 2 Sephadex Angeles, CA, USA).
Experimental Animals
C57BL/6J animals were purchased from The Jackson Laboratory. The generation and breeding of Duffy KO mice has been previously described. 18, 23 All experimental procedures were performed in 8-12 week old male mice. Animal studies were conducted in accordance with the Institutional Animal Care and Use Committee at the University of Pittsburgh. The animals were housed and maintained in a pathogen free environment by the Department of Laboratory and Animal Research at the University of Pittsburgh.
Isolation of murine erythrocytes
C57Bl/6J or KO mice were euthanized with intraperitoneal pentobarbital (120mg/kg).
Whole blood was drawn via intracardiac puncture and collected into sterile 1-ml tuberculin syringes. CPDA (Sigma-Aldrich, St. Louis, MO, USA) solution was 
Erythrocyte Chemokine Binding Assays
Erythrocyte chemokine binding was assayed using modifications of the techniques of Darbonne et al. 12 For studies involving human erythrocytes stored under blood bank conditions, erythrocyte samples were obtained from PRBC units containing AS-5
(Institute for Transfusion Medicine, Pittsburgh, PA, USA). Six units of PRBC were sampled on days 12 and 27 of storage. Just prior to day of experiment, RBC were isolated and purified through sephadex-microcellulose columns as previously described.
Chemokine binding studies were performed within 24 hours of RBC purification. For studies using RBC from human volunteers, RBC were purified as described above and stored for 1 or 13 days.
For personal use only. on November 12, 2017 . by guest www.bloodjournal.org From Erythrocytes were counted manually and then incubated for 30 minutes at room temperature with chemokine binding buffer (DMEM + 0.1% HSA) in the presence or absence of 2 nM murine or human recombinant CCL2, murine MIP-2, human CXCL8 or CXCL1 (PeproTech, Rocky Hill, NJ, USA). The erythrocyte + chemokine suspension was layered upon a 30% sucrose cushion and centrifuged for 3 minutes at 13000 g. The supernatant was collected and frozen at -80 ºC. The erythrocyte pellet was lysed using red cell lysis buffer (500mM NaCl, 0.1% Triton-X 100 and 0.25% BSA) and then frozen at -80 ºC. Chemokines contained in the supernatant or cell lysates were measured by ELISA (R&D Systems, Minneapolis, MN, USA).
Animal preparation and experimental protocol
Tail vein injection of LPS
Mice were injected with 1.5 mg/kg LPS (from E. coli 011:B4, List Biological Laboratories, Campbell, CA, USA) via tail vein.
Transfusion of erythrocytes
Murine packed red cells were passively warmed to room temperature prior to transfusion. Animals were sacrificed at specified time points with 120 mg/kg intraperitoneal pentobarbital. Mouse necropsy, lung tissue processing and BAL have been previously described in detail. 18, 24 Cell counts and differentials were determined by counting 200
consecutive cells from cytospin preparations stained with Diff Quik. BAL total protein measurements were performed using the Bradford Assay (Thermo Fisher Scientific Inc.,
Rockford, IL, USA ).
Lung Histology. The whole lung was inflated with 3 mL of 4% paraformaldehyde, and paraffin embedded. H&E staining was performed on sections cut at 4-6 micron thickness. Images were acquired using Axiocam software (Carl Zeiss MicroImaging, Inc., Thornwood, NY, USA). Immunofluorescence was performed using rat anti-mouse GR-1 antibody (Cedarlane Laboratories, Ltd., Burlington, NC, USA), rat IgG as control (Santa Cruz Biotechnology Inc, Santa Cruz, CA, USA) and goat anti-rat Alexa 488 conjugated secondary antibody. Images were acquired using an Olympus Provus Ax70 microscope.
Lung Myeloperoxidase determination. Whole lung myeloperoxidase (MPO) activity was determined using the method described by Goldblum et al 25 . The left lung was homogenized in 50 mM potassium phosphate buffer (pH 6.0) with 0.5% hexadecyltrimethylammonium bromide (HTAB, Sigma-Aldrich, St. Louis, MO, USA) on ice. The homogenate was centrifuged at 3000 g for 10 minutes. The pellet was rehomogenized, sonicated and then freeze thawed (3 times). The suspension was centrifuged at 9,500 g for 20 minutes. The supernatant was assayed with 50mM potassium phosphate buffer containing 16.7 mg/ml o-dianisidinedihydrochloride (SigmaAldrich, St. Louis, MO, USA) and hydrogen peroxide. Absorbance at 460 nm at 10 minutes was measured using a spectrophotometer.
Plasma and BAL cytokine determination. Plasma and BAL cytokine concentrations
were measured using a Multiplex Kit (R&D Systems, Minneapolis, MN, USA).
Statistics. Results are reported as the mean ± standard error of the mean. 2 tailed
Student's t test, Mann-Whitney Rank Sum, ANOVA or Spearman's rank order correlation was used where appropriate to determine significance. Statistics were performed using SigmaPlot 10 software (Systat Software Inc., Chicago, IL, USA). P values less than or equal to 0.05 were determined to be significant.
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Results:
Transfusion of red cell concentrates does not alter lung inflammation in unstimulated mice.
We developed a method of purification of erythrocytes using modifications of a technique described by Beutler et al that removes platelets and leukocytes. 22 This method resulted in > 99% pure erythrocytes, and did not yield significant LPS contamination in packed red blood cells (Supplemental Data, Figure 1 ). We examined pH, K+, lactate, 2,3-DPG, and free hemoglobin (Hgb) levels in stored murine erythrocytes. The pH and free Hgb levels in stored murine purified RBC were comparable to levels in banked human blood at later time points (Supplemental Data, Table 1 ). The 2,3-DPG levels in murine blood were higher than in human blood. 
Systemic LPS increases lung cytokine responses and neutrophil entrapment but does not promote accumulation of neutrophils in the airspaces
LPS administration by tail vein produced a systemic inflammatory response marked by hypothermia and elevated systemic cytokines (Supplemental Data, Figure 2A -B). Local activation of cytokines occurred in the lungs, as marked by increases in BAL MIP-2, KC, IL-6, and TNF-α (p<0.05, Figure 1C ). However, mice showed no neutrophils in the airspaces 4h following onset of endotoxemia, as determined by BAL polymorphonuclear (PMN) cell counts ( Figure 1D ). This was despite increases in lung MPO activity, a marker of total lung neutrophil content, from baseline levels. Thus, systemic LPS increased lung cytokine responses and neutrophil entrapment in the microvasculature, but an additional stimulus is required for neutrophil migration into the airspaces to occur.
Erythrocyte transfusion increases BAL chemokine MIP-2 and airspace neutrophil recruitment during endotoxemia.
We next determined whether red cell transfusion can modulate existing inflammatory responses. We developed a 2 event model whereby red cell transfusion was administered following the onset of systemic endotoxemia. We transfused mice 2 h following systemic LPS challenge with either colloid control infusion or purified RBC stored for 1-2 d.
While plasma concentrations of MIP-2 showed an early increase at 2 hours (994 v 551
For personal use only. on November 12, 2017. by guest www.bloodjournal.org From pg/mL, p=0.044, Supplemental Data, Figure 3A ) and KC showed a delayed increase at 16 h following RBC transfusion when compared with Hextend ® control (20741 v 9639 pg/mL, p=0.035, Supplemental Data, Figure 3B ), there were no significant differences in plasma chemokine concentrations 4 hours after transfusion. In the lung compartment, however, BAL MIP-2 was higher in the RBC group when compared with Hextend controls 4 h after transfusion (50 v 15 pg/mL, p=0.009; Figure 2A ). The increase in BAL MIP-2 concentrations was associated with a 9 fold increase in airspace neutrophils in the 1-2 d RBC group when compared with Hextend ® controls (2433 v 255 pg/mL, p<0.001; Figure 2B ). In contrast, total neutrophil content in the lungs, as measured by MPO activity in homogenates, was not measurably different between the two groups, Figure   2B . Lung microvascular permeability, as measured by BAL total protein, was higher in the RBC transfused group but this difference was not significant pg/mL, p=0.021 for MIP-2; 4371 pg/mL versus 2735 pg/mL, p<0.001 for KC; Figure   4C ). Collectively, these findings indicate that storage dependent alterations of the erythrocyte can promote lung injury during endotoxmia.
Transfusion of Duffy KO erythrocytes amplifies lung inflammation in endotoxemic mice.
We have previously shown that the erythrocyte membrane protein Duffy antigen scavenges chemokines from the lung microvasculature during inflammatory states. 
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We determined whether complete loss of chemokine scavenging on red cell transfusates and TNF-α (p<0.05 for all comparisons, Figure 5A ) and airspace neutrophil counts (22864 versus 1434, p<0.001, Figure 5B ) when compared with animals transfused with Duffy WT red cells. This increase in airspace neutrophil migration was also associated with an increase in lung microvascular permeability (p=0.034, Figure 5C ). Thus, during endotoxemia, the complete loss of Duffy chemokine scavenging on RBC transfusates further augmented existing lung inflammatory responses and increased microvascular permeability.
Red cell chemokine scavenging is reduced with storage.
To determine whether red cell chemokine scavenging is reduced with storage, we measured the ability of red cells of varying storage duration to scavenge soluble chemokine in vitro. Murine erythrocytes incubated with 2 nM recombinant CCL2 showed a time-dependent loss of chemokine scavenging function during storage (i.e. higher soluble CCL2 concentrations) ( Figure 6A Figure 6B ). Consistent with these findings, there was a reduction in membrane associated chemokine as erythrocyte lysate chemokine concentrations decreased with storage time (p=0.011, Figure 6B ). Because Duffy is a promiscuous chemokine binding protein, we also tested red cell chemokine scavenging of MIP-2, a CXC neutrophilic chemokine. We noted similar reductions in chemokine scavenging (i.e. higher soluble MIP-2 concentrations) by WT erythrocytes over time, with MIP-2 reaching levels closer to those of Duffy KO red cells ( Figure 6C ).
Human erythrocyte chemokine scavenging and Duffy antigen expression are reduced with storage.
We determined whether the observed storage dependent alterations in murine red cell chemokine scavenging occurred in human red cells. We measured the ability of purified human red blood cells stored for various time points to scavenge soluble chemokine ( Figure 7A ). We observed an increase in soluble CCL2 concentrations with increased erythrocyte storage time ( Figure 7A ). This was associated with reduced membrane bound chemokine, as erythrocyte cell lysates showed lower CCL2 concentrations with increased storage time ( Figure 7A ). We next tested the ability of packed red blood cells (PRBCs) obtained from the blood bank to scavenge CXC chemokines ( Figure 7B ).
Erythrocyte chemokine scavenging of CXCL1 was significantly reduced (p=0.008) where as scavenging of CXCL8 was unaltered ( Figure 7B 
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Several plausible reasons exist as to why alterations in red cell CXCL8 scavenging were not observed despite reductions in CCL2 and CXCL1 scavenging. CXCL8 may bind Duffy antigen with lower affinity than CCL2 or CXCL1. In cross-competition binding studies performed using a human endothelial cell line stably expressing the Duffy antigen, we have previously shown that the ability of CXCL1 and CCL2 to compete off radiolabeled CXCL1 from Duffy binding sites is greater than by CXCL8 (cold competitor Kd 5-7 nM versus 36 nM). 27 Therefore, alterations in CXCL8 scavenging with storage duration may be difficult to observe without performing the study across multiple Multiple aspects distinguish our model from prior studies of transfusion related acute lung injury (TRALI). In a previous model, both the plasma and lipid fraction from stored platelets and RBC induced injury in perfused rat lungs ex vivo. 28 In another model, TRALI was induced by MHC Class I antibodies in vivo. 29 Our model is the first in vivo model to examine the unique properties of stored erythrocytes in modulating existing inflammatory states. Although our method of red cell storage and processing does not exactly replicate clinical RBC preservation conditions, our goal was to examine the properties of the red cell itself isolated from other constituents of red cell concentrates 
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In banked human red cell units, we found that the overall reduction in surface Duffy expression is modest and may not fully explain the significant reductions in chemokine scavenging of CXCL1 and CCL2. One possible explanation is that Duffy antigen undergoes modifications during storage which alter regions critical for chemokine binding function but that the linear epitope recognized by the Fy6 monoclonal antibody remains relatively preserved. This could also explain why scavenging of CXCL1 and CCL2 were significantly reduced but not CXCL8, as it would be expected that the chemokine binding "pocket" created by the tertiary structure is different for different ligands.
In the murine studies, the complete loss of erythrocyte chemokine scavenging function during endotoxemia results in significantly higher local chemokine concentrations. As red cells traverse the lung microvasculature, the inability of a red cell to scavenge chemokines rapidly creates a local chemotactic gradient that favors entrapped neutrophils in the lung microvasculature to migrate into the airspaces. This is supported by significantly higher BAL chemokine concentrations in mice transfused Duffy KO erythrocytes and prior findings of Darbonne and colleagues that showed the ability of red cells to deplete chemokine across the compartments of a diffusion chamber. For personal use only. on November 12, 2017. by guest www.bloodjournal.org From
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